Abstract
Cardiac transplantation is the only treatment option for significant, irreversible functional impairment of the heart despite maximal medical therapy. The most common causes in adults are either idiopathic dilated cardiomyopathy or ischaemic cardiomyopathy caused by coronary artery disease. In children, indications are frequently complex congenital heart malformations, in many cases after multiple surgical palliations, or hereditary dilated cardiomyopathies.
Cardiac transplant candidates need careful evaluation of co-morbidities and optimal medical management during waiting time. After allocation of a donor heart, donor and recipient operation for orthotopic heart transplantation is based on the technique developed by Lower and Shumway. The implantation might be complicated by previous cardiac operations or by the use of a mechanical circulatory support device.
Indications for combined heart and lung transplantations are declining, nowadays limited to patients with terminal double organ failure, mostly due to congenital heart disease with subsequent severe treatment-resistant pulmonary hypertension. The surgical technique was developed by Bruce Reitz and coworkers at Stanford University.
The most common complication in the first year after transplantation is acute cellular rejection. For prevention, roughly 50 % of transplant centres use initial antibody induction therapy. Most maintenance immunosuppressive protocols employ a three-drug regimen consisting of a calcineurin inhibitor, an antimetabolite agent, and tapering doses of glucocorticoids.
Besides the underlying disease and the development of transplant-specific graft vessel disease, a major problem in long-term heart transplant recipients remains that is the complications caused by chronic treatment with immunosuppressive compounds.
References
Aaronson KD, Schwartz JS, Chen TM et al. (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667
Aigner C, Winkler G, Jaksch P et al. (2005) Extended donor criteria for lung transplantation—a clinical reality. Eur J Cardiothorac Surg 27:757–761
Aliabadi A, Grömmer M, Zuckermann A (2011) Is induction therapy still needed in heart transplantation? Curr Opin Organ Transpl 16:536–542
Bailey L, Concepcion W, Shattuck H, Huang L (1986) Method of heart transplantation for treatment of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 92:1–5
Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 325:225–235
Barnard CN (1967) The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41:1271–1274
Belzer FO, Southhard JH (1988) Principles of solid-organ preservation by cold storage. Transplantation 21:673–686
Billingham ME (1981) Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transpl 1:25–30
Bretschneider HJ, Hübner G, Knoll D et al. (1975) Myocardial resistance and tolerance to ischemia: physiological an biochemical basis. J Cardiovasc Surg 16:241–260
Cantarovich M, Giannetti N, Barkun J et al. (2004) Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction. Transplantation 78:779–781
Carrel A, Guthrie CC (1905) The transplantation of veins and organs. Am Med 10:1101–1102
Carrier M, White M, Perrault LP et al. (1999) A 10-year experience with intravenous thymoglobulin in induction of immunosuppression following heart transplantation. J Heart Lung Transplant 18:1218–1223
Caves PK, Stinson EB, Billingham ME, Shumway NE (1974) Serial tansvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet 1:821–826
Chang D, Kobashigawa J (2012) The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation. Curr Opin Organ Transplant 17:423–426
Chin C, Naftel D, Pahl E et al. (2006) Cardiac re-transplantation in pediatrica: a multi-institutional study. J Heart Lung Transplant 25:1420–1424
Cooney GF, Jeevanandam V, Choudhury S et al. (1998) Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc 30:1892–1894
DiBardino DJ (1999) The history and development of cardiac transplantation. Tex Heart Inst J 26:198–205
Dipchand AI, Rossano JW et al. (2015) The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Heart Transplantation Report–2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34:1233–1243
Dreyfus G, Jebara V, Mihaileanu S, Carpentier AF (1991) Total orthotopic heart transplantation: an alternative to the standard technique. Ann Thorac Surg 52:1181–1184
Groetzner J, Reichart B, Roemer U et al. (2005) Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Ann Thorac Surg 79:53–61
Goldfarb SB, Benden C, Edwards LB et al. (2015) The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Lung and Heart-Lung Transplantation Report–2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34:1255–1263
Groetzner J, Kaczmarek I, Schulz U et al. (2009) Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation 87:726–733
Gronda E, Bourge RC, Costanzo MR et al. (2006) Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006. J Heart Lung Transplant 25:1043–1056
Hölscher M, Groenewoud AF (1991) Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 23:2334–2337
Hübner T, Nickel T, Steinbeck G et al. (2015) A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list. Clin Res Cardiol 104:929–934
Hunt SA, Burch M et al. (2012) ISHLT Guidelines for the care of heart transplant recipients. Part 3: Longterm care. ISHLT Monograph Series 6:173–246
Jacobs S, Rega F, Meyns B (2010) Current preservation technology and future prospects of thoracic organs. Part 2: heart. Curr Opin Organ Transplant 15:156–159
Jessup M, Banner N, Brozena S et al. (2006) Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006. J Heart Lung Transplant 25:1003–1023
Kajihara N, Morita S, Tanoue Y et al. (2006) The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur J Cardiothorac Surg 29:784–789
Kobashigawa J, Miller L, Renlund D et al. (1998) A randomized active controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 66:507–515
Kobashigawa J, Mehra M, West L et al. (2009) Consensus conference: participants report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 28:213–225
Kobashigawa J, Crespo-Leiro MG, Ensminger SM et al. (2011) Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 30:252–269
Lehmkuhl H, Arizon J, Vigano M et al. (2009) Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients. Transplantation 88:115–122
Losman JG, Barnard CN, Barcaly TD (1977) Hemodynamic evaluation of left ventricular bypass with a homologous cardiac graft. J Thorac Cardiovasc Surg 74:695–708
Lower RR, Shumway NE (1960) Studies on the orthotopic homotransplantations of the canine heart. Surg Forum 11:18–19
Lower RR, Stofer RC, Hurley EJ et al. (1962) Successful homotransplantations of the canine heart after anoxic preservation for seven hours. Am J Surg 104:302
Lower RR, Dong E, Shumway NE (1965) Long-term survival of cardiac homografts. Surgery 58:110–119
Lund LH, Edwards LB, Kucheryavaya AY et al. (2015) The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report–2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34:1244–1254
Maathuis MHJ, Leuvenink HGD, Ploeg RJ (2007) Perspectives in organ preservation. Transplantation 83:1289–1298
Mehra MR, Kobashigawa J, Starling R (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006. J Heart Lung Transplant 25:1024–1042
Meiser BM, Überfuhr P, Fuchs A et al. (1998) Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 17:782–788
Meiser BM, Pfeiffer M, Schmidt D et al. (1999) Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. J Heart Lung Transplant 18:143–149
Meiser BM, Kaczmarek I, Müller M et al. (2007) Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious. J Heart Lung Transplant 26:598–603
Meiser B, Buchholz S, Kaczmarek I (2011) De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results. Curr Opin Organ Transplant 16:522–528
Menasche P, Termingnon JL, Pradier F et al. (1994) Expertimental evaluation of Celsior, a new heart preservation solution. Eur Cardiothorac Surg 8:207–213
Morris RE, Meiser BM (1989) Identification of a new pharmacologic action for an old compound. Med Sci Res 17:609–610
Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Müller C, Fürst H, Reichenspurner H, Briegel J et al. (1999) Lung procurement by low-potassium, dextran an the effect on preservation injury. Transplantation 68:1139–1143
Nathan HM, Conrad SL, Held PJ et al. (2003) Organ donation in the United States. Am J Transplant 3(Suppl 4):29–40
Novitzky D, Cooper DK, Barnard CN (1983) The surgical technique of heterotopic heart transplantation. Ann Thorac Surg 36:476–482
Novitzky D, Wicomb WN, Cooper DKC et al. (1984) Electrocardiographic, haemodynamic an endocrine changes occurring during expertmental brain death in the Chacma baboon. J Heart Transplant 4:63–69
Novitzky D, Cooper DKG, Lanza RP, Barnard CN (1985) Further cardiac transplant procedures in patients with heterotopic heart transplants. Ann Thorac Surg 39:149–154
Novitzky D, Cooper DKC, Brink JG et al. (1987) Sequential—second and third—transplants in patients with heterotopic heart allografts. Clin Transplant 1:57–62
Oyer P, Stinson E, Jamieson S et al. (1983) CYA in cardiac transplantation: a 2 1/2 year follow-up. Transplant Proc 15:2546
Pahl E, Naftel DC, Kuhn MA et al. (2005) The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant 24:945–951
Patterson GA, Cooper JD (1988) Status of lung transplantation. Surg Clin North Am 68:545–558
Pham SM, Kormos RL, Hattler BG et al. (1996) A prospective trial of tacrolimus (FK506) in clinical heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 111:764–772
Reichart B, Meiser BM, Viganò M et al. (1998) European multicenter tacrolimus (FK506) heart pilot study; one-year results—European tacrolimus multicenter heart study group. J Heart Lung Transplant 17:775–781
Reitz BA, Burton NA, Jamieson SW et al. (1980) Heart and lung transplantation, autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg 80:360–372
Rosenthal D, Chrisant MRK, Edens E et al. (2004) ISHLT: practice guidelines for management of heart failure in children. J Heart Lung Transplant 23:1313–1333
Ross M, Kouretas P, Gamberg P et al. (2006) Ten- and 20-year survivor of pediatric orthotopic heart transplantation. J Heart Lung Transplant 25:261–270
Sarsam MA, Campell CS, Yonan NA, Deiraniya AK, Rahman AN (1993) An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg 8:344–349
Steen S, Paskevicius A, Liao Q et al. (2016) Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand Cardiovasc J 50:193–200
Stewart S, Winters GL, Fishbein MC et al. (2005) Revision of the1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24:1710–1720
Taylor DO, Barr ML, Radovancevic B et al. (1999) Randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regiments in cardiac transplantation; decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18:336–345
Taylor DO, Meiser BM, Webber SA, et al. (2012) ISHLT guidelines for the care of heart transplant recipients. Part 2: Immunosuppression and rejection. ISHLT Monograph Series 6:97–172
von Scheidt W, Pauschinger M, Ertl G (2016) Long-term intravenous inotropes in low-output terminal heart failure? Clin Res Cardiol 105:471–481
Wenke K, Meiser B, Thiery J et al. (1997) Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 96:1398–1402
West LJ, Pollock-Barziv SM, Dipchand AI et al. (2001) ABO-incompatible heart transplantation in infants. N Engl J Med 344:793–800
Yacoub MH, Banner NR, Khaghani A et al. (1990) Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant 9:459–466; discussion 466—467
Yusen RD, Edwards LB, Kucheryavaya AY et al. (2015) The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report – 2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34:1264–1277
Zaroff JG, Rosengard BR, Armstrong WF et al. (2002) Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. J Heart Lung Transplant 21:1153–1160
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Meiser, B., Reichart, B. (2017). Heart and Heart–Lung Transplantation. In: Ziemer, G., Haverich, A. (eds) Cardiac Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52672-9_37
Download citation
DOI: https://doi.org/10.1007/978-3-662-52672-9_37
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52670-5
Online ISBN: 978-3-662-52672-9
eBook Packages: MedicineMedicine (R0)